Search Results - Atasoy, Ajlan

Current status of immunotherapy and immune biomarkers in gastro-esophageal cancers by Ammannagari, Nischala, Atasoy, Ajlan

Get full text Get full text Get full text

Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in Turkey by Ozmen, Vahit, Atasoy, Ajlan, Gokmen, Erhan, Ozdogan, Mustafa, Guler, Nilufer, Uras, Cihan, Ok, Engin, Demircan, Orhan, Isikdogan, Abdurrahman, Saip, Pinar

Get full text Get full text Get full text

Phase II Study of Irinotecan Plus Panitumumab as Second‐Line Therapy for Patients with Advanced Esophageal Adenocarcinoma by Yoon, Harry, Karapetyan, Lilit, Choudhary, Anita, Kosozi, Ramla, Bali, Gurvinder Singh, Zaidi, Ali H., Atasoy, Ajlan, Forastiere, Arlene A., Gibson, Michael K.

Get full text Get full text Get full text

Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in Turkey by Özmen, Vahit, Atasoy, Ajlan, Gökmen, Erhan, Özdoğan, Mustafa, Güler, Nilufer, Uras, Cihan, Ok, Engin, Demircan, Orhan, Işıkkdoğan, Abdurrahman, Cabioğlu, Neslihan, Şen, Fatma, Saip, Pınar

Get full text Get full text Get full text

Safety of Nivolumab plus Low‐Dose Ipilimumab in Previously Treated Microsatellite Instability‐High/Mismatch Repair‐Deficient Metastatic Colorectal Cancer by Morse, Michael A., Overman, Michael J., Hartman, Leighanne, Khoukaz, Taline, Brutcher, Edith, Lenz, Heinz‐Josef, Atasoy, Ajlan, Shangguan, Tong, Zhao, Huanyu, El‐Rayes, Bassel

Get full text Get full text Get full text

Barrett’s esophagus and animal models by Macke, Ryan A., Nason, Katie S., Mukaisho, Ken-ichi, Hattori, Takanori, Fujimura, Takashi, Sasaki, Shozo, Oyama, Katsunobu, Miyashita, Tomoharu, Ohta, Tetsuo, Miwa, Koichi, Zaidi, Ali, Malhotra, Usha, Atasoy, Ajlan, Foxwell, Tyler, Jobe, Blair

Get full text Get full text Get full text